Laflamme M, et al. - In this retrospective cohort study, researchers determined the incidence of intraoperative periprosthetic fractures following an intracapsular displaced hip fracture treated with this particular cemented stem compared with the previous implant. For this investigation, they compared a historic cohort of hip fractures treated with the OmniFit Eon® (Stryker, NJ, USA) cemented stem with a new cohort of patients who received the Corail® (Depuy Synthes, IN, USA) cemented stem. There were 348 patients receiving the Corail stem in the treatment group and there were 77 patients in the control group. Except for the presence of dementia, the two groups had comparable baseline features. Data reported that the incidence of intraoperative calcar or greater trochanteric fracture for the Corail group was 15.5% and the control group was 2.7%. The Corail cemented stem exhibits an abnormal number of iatrogenic intraoperative fractures in the geriatric population following displaced femoral neck fracture. There appears to be no external factor explaining this high number of fractures. It is important to question the design of the implant.